However, the role of IFNs in RA is less well understood, and tumour necrosis factor (TNF)‐α has generally been considered to be the predominant cytokine that drives disease progression, based on the success of therapeutic TNF‐α blockade [TNF inhibitor (TNF‐i)] [9, 10]. This evidence concerns the gene TNF and rheumatoid arthritis.